CH638052A5 - Verfahren und automatisierte analysenvorrichtung zur bestimmung einer immunochemisch reaktionsfaehigen substanz in einer koerperfluessigkeit. - Google Patents

Verfahren und automatisierte analysenvorrichtung zur bestimmung einer immunochemisch reaktionsfaehigen substanz in einer koerperfluessigkeit. Download PDF

Info

Publication number: CH638052A5
Authority: CH; Switzerland
Prior art keywords: particles; test; reactance; reagent; receptor
Prior art date: 1977-11-03

Application number

CH1125478A

Other languages

German (de)

English (en)

Inventor

Richard Calvin Ebersole

Original Assignee

Du Pont

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-11-03

Filing date

1978-11-01

Publication date

1983-08-31

1978-09-18 Priority claimed from US05/942,261 external-priority patent/US4219335A/en

1978-11-01 Application filed by Du Pont filed Critical Du Pont

1983-08-31 Publication of CH638052A5 publication Critical patent/CH638052A5/de

Links

238000000034 method Methods 0.000 title claims description 31
239000000126 substance Substances 0.000 title claims description 26
239000007788 liquid Substances 0.000 title claims description 4
238000004458 analytical method Methods 0.000 title description 2
238000012360 testing method Methods 0.000 claims description 64
239000003153 chemical reaction reagent Substances 0.000 claims description 44
239000002245 particle Substances 0.000 claims description 33
230000005291 magnetic effect Effects 0.000 claims description 22
210000001124 body fluid Anatomy 0.000 claims description 16
239000010839 body fluid Substances 0.000 claims description 16
102000004169 proteins and genes Human genes 0.000 claims description 14
108090000623 proteins and genes Proteins 0.000 claims description 14
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 12
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 9
239000003550 marker Substances 0.000 claims description 9
239000006249 magnetic particle Substances 0.000 claims description 7
239000000427 antigen Substances 0.000 claims description 6
102000036639 antigens Human genes 0.000 claims description 6
108091007433 antigens Proteins 0.000 claims description 6
229910052759 nickel Inorganic materials 0.000 claims description 6
239000002184 metal Substances 0.000 claims description 5
229910044991 metal oxide Inorganic materials 0.000 claims description 5
150000004706 metal oxides Chemical class 0.000 claims description 5
229910052742 iron Inorganic materials 0.000 claims description 4
229910052751 metal Inorganic materials 0.000 claims description 4
230000008859 change Effects 0.000 claims description 3
239000012530 fluid Substances 0.000 claims description 3
239000000696 magnetic material Substances 0.000 claims description 3
230000002285 radioactive effect Effects 0.000 claims description 3
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 2
229910052804 chromium Inorganic materials 0.000 claims description 2
239000011651 chromium Substances 0.000 claims description 2
229910052748 manganese Inorganic materials 0.000 claims description 2
239000011572 manganese Substances 0.000 claims description 2
239000000376 reactant Substances 0.000 claims description 2
230000035945 sensitivity Effects 0.000 claims description 2
238000001179 sorption measurement Methods 0.000 claims description 2
238000012795 verification Methods 0.000 claims description 2
241000251468 Actinopterygii Species 0.000 claims 2
230000015572 biosynthetic process Effects 0.000 claims 2
230000005611 electricity Effects 0.000 claims 2
238000005755 formation reaction Methods 0.000 claims 2
230000000007 visual effect Effects 0.000 claims 2
229960000182 blood factors Drugs 0.000 claims 1
239000003795 chemical substances by application Substances 0.000 claims 1
238000003776 cleavage reaction Methods 0.000 claims 1
239000012141 concentrate Substances 0.000 claims 1
238000010411 cooking Methods 0.000 claims 1
239000012634 fragment Substances 0.000 claims 1
230000028993 immune response Effects 0.000 claims 1
230000000984 immunochemical effect Effects 0.000 claims 1
238000002955 isolation Methods 0.000 claims 1
238000002372 labelling Methods 0.000 claims 1
238000009597 pregnancy test Methods 0.000 claims 1
239000012857 radioactive material Substances 0.000 claims 1
230000009257 reactivity Effects 0.000 claims 1
230000007017 scission Effects 0.000 claims 1
238000009600 syphilis test Methods 0.000 claims 1
102000005962 receptors Human genes 0.000 description 21
108020003175 receptors Proteins 0.000 description 21
238000006243 chemical reaction Methods 0.000 description 14
239000000463 material Substances 0.000 description 10
239000000243 solution Substances 0.000 description 9
150000001875 compounds Chemical class 0.000 description 8
238000011067 equilibration Methods 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
239000007983 Tris buffer Substances 0.000 description 5
230000000694 effects Effects 0.000 description 5
239000000523 sample Substances 0.000 description 5
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
102000009027 Albumins Human genes 0.000 description 4
108010088751 Albumins Proteins 0.000 description 4
241000283707 Capra Species 0.000 description 4
229920002292 Nylon 6 Polymers 0.000 description 4
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
108091006905 Human Serum Albumin Proteins 0.000 description 3
102000008100 Human Serum Albumin Human genes 0.000 description 3
229940098773 bovine serum albumin Drugs 0.000 description 3
239000007853 buffer solution Substances 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
239000010941 cobalt Substances 0.000 description 3
229910017052 cobalt Inorganic materials 0.000 description 3
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 3
239000012470 diluted sample Substances 0.000 description 3
238000005259 measurement Methods 0.000 description 3
150000002739 metals Chemical class 0.000 description 3
150000002894 organic compounds Chemical class 0.000 description 3
239000012071 phase Substances 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
229910000077 silane Inorganic materials 0.000 description 3
NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
239000004952 Polyamide Substances 0.000 description 2
108010071390 Serum Albumin Proteins 0.000 description 2
102000007562 Serum Albumin Human genes 0.000 description 2
239000000956 alloy Substances 0.000 description 2
229910045601 alloy Inorganic materials 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
239000000872 buffer Substances 0.000 description 2
150000001718 carbodiimides Chemical class 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
238000004132 cross linking Methods 0.000 description 2
239000013078 crystal Substances 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
-1 europium chalcogenide Chemical class 0.000 description 2
239000011554 ferrofluid Substances 0.000 description 2
239000011888 foil Substances 0.000 description 2
239000005556 hormone Substances 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
230000005415 magnetization Effects 0.000 description 2
230000000737 periodic effect Effects 0.000 description 2
230000035699 permeability Effects 0.000 description 2
229920002647 polyamide Polymers 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
229920002799 BoPET Polymers 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
229910052693 Europium Inorganic materials 0.000 description 1
230000005355 Hall effect Effects 0.000 description 1
241000709721 Hepatovirus A Species 0.000 description 1
241000282412 Homo Species 0.000 description 1
241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
239000005041 Mylar™ Substances 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
229920003182 Surlyn® Polymers 0.000 description 1
241000700605 Viruses Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000004913 activation Effects 0.000 description 1
229910000828 alnico Inorganic materials 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
230000003321 amplification Effects 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
230000008901 benefit Effects 0.000 description 1
239000003139 biocide Substances 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000005387 chalcogenide glass Substances 0.000 description 1
150000004770 chalcogenides Chemical class 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
AYTAKQFHWFYBMA-UHFFFAOYSA-N chromium(IV) oxide Inorganic materials O=[Cr]=O AYTAKQFHWFYBMA-UHFFFAOYSA-N 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
229940126543 compound 14 Drugs 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
239000011162 core material Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000003814 drug Substances 0.000 description 1
YYXLGGIKSIZHSF-UHFFFAOYSA-N ethene;furan-2,5-dione Chemical compound C=C.O=C1OC(=O)C=C1 YYXLGGIKSIZHSF-UHFFFAOYSA-N 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000004744 fabric Substances 0.000 description 1
230000005294 ferromagnetic effect Effects 0.000 description 1
230000005307 ferromagnetism Effects 0.000 description 1
208000005252 hepatitis A Diseases 0.000 description 1
125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
229920000554 ionomer Polymers 0.000 description 1
UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
235000013980 iron oxide Nutrition 0.000 description 1
VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
239000006194 liquid suspension Substances 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229920000620 organic polymer Polymers 0.000 description 1
239000013610 patient sample Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000002953 phosphate buffered saline Substances 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

CH1125478A 1977-11-03 1978-11-01 Verfahren und automatisierte analysenvorrichtung zur bestimmung einer immunochemisch reaktionsfaehigen substanz in einer koerperfluessigkeit. CH638052A5 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US84821777A	1977-11-03	1977-11-03
US05/942,261 US4219335A (en)	1978-09-18	1978-09-18	Immunochemical testing using tagged reagents

Publications (1)

Publication Number	Publication Date
CH638052A5 true CH638052A5 (de)	1983-08-31

Family

ID=27126757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH1125478A CH638052A5 (de)	1977-11-03	1978-11-01	Verfahren und automatisierte analysenvorrichtung zur bestimmung einer immunochemisch reaktionsfaehigen substanz in einer koerperfluessigkeit.

Country Status (16)

Country	Link
JP (1)	JPS5912139B2 (fr)
AU (1)	AU522995B2 (fr)
CA (1)	CA1122503A (fr)
CH (1)	CH638052A5 (fr)
DE (1)	DE2847282A1 (fr)
DK (1)	DK489678A (fr)
FI (1)	FI783346A7 (fr)
FR (1)	FR2408142A1 (fr)
GB (1)	GB2008767B (fr)
IE (1)	IE47482B1 (fr)
IL (1)	IL55856A (fr)
IT (1)	IT1101280B (fr)
LU (1)	LU80471A1 (fr)
NL (1)	NL7810910A (fr)
NO (1)	NO151099C (fr)
SE (1)	SE431257B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2136130B (en) *	1983-02-28	1987-02-11	Theodore Henry Krueger	Chemical assay systems and methods
CA1220818A (fr) *	1983-05-05	1987-04-21	Hugh A.O. Hill	Methodes d'essais biologiques utilisant des agents de liaison specifiques
GB8314523D0 (en) *	1983-05-25	1983-06-29	Lowe C R	Diagnostic device
EP0139373A1 (fr) *	1983-08-26	1985-05-02	The Regents Of The University Of California	Système pour immunoessais multiples
JPS6055265A (ja) *	1983-09-06	1985-03-30	Fujirebio Inc	磁性粒子を用いた抗原、抗体の測定方法
GB8331514D0 (en) *	1983-11-25	1984-01-04	Janssen Pharmaceutica Nv	Visualization method
AU596946B2 (en) *	1984-07-10	1990-05-24	F. Hoffmann-La Roche Ltd	Methods of assay
FI844027A7 (fi) *	1984-10-12	1986-04-13	Labsystems Oy	Immunologiskt bestaemningsfoerfarande.
JPH0823558B2 (ja) *	1984-11-27	1996-03-06	オ−ジエニクスリミテツド	検定装置
LU86239A1 (fr) *	1986-01-02	1987-09-03	Sanders Probel Lab	Methode de detection d'agents reactifs et moyens de mise en oeuvre de cette methode
US4794089A (en) *	1986-03-25	1988-12-27	Midwest Research Microscopy, Inc.	Method for electronic detection of a binding reaction
US5374524A (en) *	1988-05-10	1994-12-20	E. I. Du Pont De Nemours And Company	Solution sandwich hybridization, capture and detection of amplified nucleic acids
US5137804A (en) *	1988-05-10	1992-08-11	E. I. Du Pont De Nemours And Company	Assay device and immunoassay
GB2270976A (en) *	1992-09-18	1994-03-30	Marconi Gec Ltd	Immunoassay/separation process using an auxiliary species on a support
RU2225985C2 (ru) *	1998-09-08	2004-03-20	Тиботек Н.В.	Способ быстрого скрининга анализируемых проб
US6544480B1 (en)	1999-10-26	2003-04-08	Tibotec Bvba	Device and related method for dispensing small volumes of liquid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1479661A (en) *	1972-06-26	1977-07-13	Gen Electric	Method and apparatus for detection and purification of proteins and antibodies
GB1500127A (en) *	1973-10-10	1978-02-08	Abbott Lab	Reactive matrices
US4020151A (en) *	1976-02-17	1977-04-26	International Diagnostic Technology, Inc.	Method for quantitation of antigens or antibodies on a solid surface
IL49685A (en) *	1976-05-31	1978-10-31	Technion Res & Dev Foundation	Specific binding assay method for determining the concentration of materials and reagent means therefor
US4087248A (en) *	1976-07-26	1978-05-02	Miles Laughton E	Multiple assay machine and method

1978
- 1978-10-03 SE SE7810351A patent/SE431257B/sv not_active IP Right Cessation
- 1978-10-31 DE DE19782847282 patent/DE2847282A1/de not_active Withdrawn
- 1978-10-31 CA CA315,018A patent/CA1122503A/fr not_active Expired
- 1978-11-01 GB GB7842707A patent/GB2008767B/en not_active Expired
- 1978-11-01 CH CH1125478A patent/CH638052A5/de not_active IP Right Cessation
- 1978-11-02 IL IL55856A patent/IL55856A/xx unknown
- 1978-11-02 FR FR7831041A patent/FR2408142A1/fr active Granted
- 1978-11-02 AU AU41283/78A patent/AU522995B2/en not_active Expired
- 1978-11-02 IE IE2168/78A patent/IE47482B1/en unknown
- 1978-11-02 IT IT7829378A patent/IT1101280B/it active
- 1978-11-02 FI FI783346A patent/FI783346A7/fi unknown
- 1978-11-02 JP JP53134678A patent/JPS5912139B2/ja not_active Expired
- 1978-11-02 DK DK489678A patent/DK489678A/da not_active Application Discontinuation
- 1978-11-02 NL NL7810910A patent/NL7810910A/xx not_active Application Discontinuation
- 1978-11-02 NO NO783691A patent/NO151099C/no unknown
- 1978-11-03 LU LU80471A patent/LU80471A1/fr unknown

Also Published As

Publication number	Publication date
JPS5491296A (en)	1979-07-19
NL7810910A (nl)	1979-05-07
JPS5912139B2 (ja)	1984-03-21
FR2408142A1 (fr)	1979-06-01
IE47482B1 (en)	1984-04-04
FR2408142B1 (fr)	1984-02-17
CA1122503A (fr)	1982-04-27
NO151099B (no)	1984-10-29
GB2008767B (en)	1982-06-30
NO783691L (no)	1979-05-04
SE7810351L (sv)	1979-05-04
DE2847282A1 (de)	1979-05-10
SE431257B (sv)	1984-01-23
IL55856A0 (en)	1979-01-31
IT1101280B (it)	1985-09-28
DK489678A (da)	1979-05-04
LU80471A1 (fr)	1979-06-15
AU522995B2 (en)	1982-07-08
IT7829378A0 (it)	1978-11-02
IE782168L (en)	1980-03-18
FI783346A7 (fi)	1979-05-04
NO151099C (no)	1985-02-06
GB2008767A (en)	1979-06-06
AU4128378A (en)	1979-05-17
IL55856A (en)	1981-11-30

Legal Events

Date	Code	Title	Description
1988-07-29	PL	Patent ceased
2024-10-31	PL	Patent ceased

Publication	Publication Date	Title
DE3685600T2 (de)	1993-01-21	Stabilisierte fluoreszierende seltenerd-indikatoren und physiologisch-reaktive kennsatz-spezies.
US4219335A (en)	1980-08-26	Immunochemical testing using tagged reagents
CH638052A5 (de)	1983-08-31	Verfahren und automatisierte analysenvorrichtung zur bestimmung einer immunochemisch reaktionsfaehigen substanz in einer koerperfluessigkeit.
DE60024448T2 (de)	2006-08-24	System zur elektrochemischen quantitativen analyse von analyten in einer festphase
DE69934091T2 (de)	2007-06-21	Test zur bestimmung von kraftdiskriminierung
DE69812329T2 (de)	2004-02-12	Multiplex-zufluss-immunotest mit magnetischen teilchen als festphase
DE3872621T2 (de)	1993-02-18	Nachweis von umgebenden konzentrationen mehrerer analyten.
DE69128618T2 (de)	1998-05-07	Vorrichtung und verfahren zur ausführung von immunoassays
EP0805983B1 (fr)	2000-01-12	Procede et composes permettant d'effectuer une detection magnetorelaxometrique d'analytes et leur utilisation
DE3586909T2 (de)	1993-04-29	Testverfahren.
DE3689618T2 (de)	1994-05-11	Magnetische polymerteilchen.
DE69231362T2 (de)	2000-12-28	Gleichzeitiges testen von arzneimitteln und fingerabdrucktestverfahren
DE68911674T2 (de)	1994-04-07	Testverfahren und reagenzsatz dazu.
DE2618386C2 (de)	1985-02-07	Diagnostisches Verfahren zum Bestimmen der Anwesenheit oder Abwesenheit nachzuweisender biologischer Teilchen
DE69226916T2 (de)	1999-05-12	Einfache analysenvorrichtung
DE3382785T2 (de)	1995-10-05	Aufsätze zum Gebrauch in Enzymimmunotests und Verfahren zur Herstellung dieser Aufsätze.
DE68919565T2 (de)	1995-06-29	Immuntestverfahren unter Verwendung magnetischer Markerteilchen.
DE60311906T2 (de)	2007-11-15	Direktes Immunosensortestverfahren
DE2522087A1 (de)	1975-12-11	Biologische analyse
DE69836493T2 (de)	2007-09-06	Vorrichtung zur bestimmung von mehreren analyten
EP0998675B1 (fr)	2010-03-17	Utilisation de surfaces de controle pour detecter des echantillons perturbes dans un procede de detection
DE2849708A1 (de)	1979-05-23	Verfahren zur feststellung und quantitativen bestimmung biologisch wichtiger substanzen
DE69333569T2 (de)	2005-08-04	Magnetisch assistierte bindungsassays unter verwendung von magnetisch markierten bindungspartnern.
DE2632478A1 (de)	1977-02-24	Verfahren zur erfassung und trennung von antigenen und antikoerperchen im blut und in anderen proben
DE2902676A1 (de)	1979-08-02	Immunoassays unter verwendung von f(ab') tief 2 -untergruppen